Study on relaxing rules for lung cancer trial participation
Part of Cancer, Lungs & breathing clinical trials.
This study looks at real-world data from people with advanced non-small cell lung cancer to see how making trial rules less strict might affect who can join. It may help make future trials more inclusive.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with stage IIIB, IIIC, or IV non-small cell lung cancer between January 2013 and December 2022.
- You have had at least two doctor visits recorded since January 2013.
- Your cancer diagnosis was listed using the ICD-10 code for non-small cell lung cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects real-world information about people with lung cancer who get newer kinds of cancer drugs. It aims to understand how these innovative therapies work in everyday care and help future research.
This trial is looking at how well a lung cancer treatment improves survival. It enrolls adults with confirmed lung cancer who can safely take the study medicines and have cancer that can be measured on scans.
This study follows adults with confirmed lung cancer as they are diagnosed and treated in routine clinical practice. It aims to better understand how lung cancer is diagnosed and managed day-to-day, which may help improve future care.
This trial tests approved cancer drugs in people aged 70 and older with non-small-cell lung cancer who haven't had systemic treatment before. The goal is to see how well these drugs work in this older population.
This is an observational study of people with lung cancer. The goal is to better understand care patterns and outcomes; joining would involve giving consent and answering study questions.
This study helps hospitals use the latest lung cancer guidelines better. If you have NSCLC or ES-SCLC and haven't had recent treatment, this trial may help improve the quality of care you receive.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.